Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19Comparative Study Published on 2022-11-012023-07-10 Journal: The Korean journal of internal medicine [Category] [DOI] 10.3904/kjim.2022.173 PMC 바로가기 [Article Type] Comparative Study
A model of COVID-19 pandemic with vaccines and mutant virusesArticle Published on 2022-10-242022-11-16 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0275851 PMC 바로가기
SARS-CoV-2 Infectivity and Antibody Titer Reduction for 6 Months After Second Dose of BNT162b2 mRNA Vaccine in Health Care Workers: A Prospective Cohort Study의료 종사자에서 BNT162b2 mRNA 백신 2차 접종 후 6개월 동안 SARS-CoV-2 감염성 및 항체 역가 감소: 전향적 코호트 연구Article Published on 2022-08-122022-09-12 Journal: The Journal of Infectious Diseases [Category] [DOI] 10.1093/infdis/jiac035 PMC 바로가기 [Article Type] Article
Short-Term Effect of SARS-CoV-2 Spike Protein Receptor-Binding Domain-Specific Antibody Induction on Neutrophil-Mediated Immune Response in Mice쥐의 호중구 매개 면역 반응에 대한 SARS-CoV-2 스파이크 단백질 수용체 결합 도메인 특이적 항체 유도의 단기 효과Article Published on 2022-07-262022-09-12 Journal: International Journal of Molecular Sciences [Category] [DOI] 10.3390/ijms23158234 PMC 바로가기 [Article Type] Article
Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care CenterSARS-CoV-2 감염 후 혈청전환율 및 ChAdOx1-nCOV COVISHIELD™ 또는 BBV-152 COVAXIN™ 백신 2회 접종 후 신장 동종이식 환자: 2개의 공립 및 사립 3차 치료 센터 경험Article Published on 2022-06-302022-09-12 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.911738 PMC 바로가기 [Article Type] Article
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies항암치료를 받는 환자의 코로나19 백신접종에 대한 항체 및 T세포 반응Article Published on 2022-06-012022-09-11 Journal: Journal for immunotherapy of cancer [Category] [DOI] 10.1136/jitc-2022-004766 PMC 바로가기 [Article Type] Article
Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot studyCOVID-19에 대한 새로운 보조 요법으로서 장내 미생물총 유래 신바이오틱 포뮬라(SIM01): 오픈 라벨 파일럿 연구Article Published on 2022-05-012022-09-12 Journal: Journal of gastroenterology and hepatology [Category] [DOI] 10.1111/jgh.15796 PMC 바로가기 [Article Type] Article
Mechanisms and clinical evidence to support melatonin’s use in severe COVID-19 patients to lower mortalityReview article Published on 2022-04-012022-10-05 Journal: Life sciences [Category] [DOI] 10.1016/j.lfs.2022.120368 [Article Type] Review article
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab중화 단일클론항체 밤라니비맙 치료 후 코로나19로 입원한 환자의 비인두 면봉 유전자 발현 패턴과 혈청 바이오마커 간의 관계Randomized Controlled Trial Published on 2022-03-182022-09-11 Journal: Journal of Translational Medicine [Category] [DOI] 10.1186/s12967-022-03345-3 PMC 바로가기 [Article Type] Randomized Controlled Trial
Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19경증 또는 중증 COVID-19 환자와 COVID-19 백신 1차 및 2차 접종 후 항체 반응 비교Comparative Study Published on 2022-03-012022-09-11 Journal: The Korean journal of internal medicine [Category] [DOI] 10.3904/kjim.2021.409 PMC 바로가기 [Article Type] Comparative Study